Alert icon
We're changing our privacy policy. This stuff matters.  Learn more  Dismiss

Dr. David Calkins on innovative glaucoma research

Loading...

Sign in or sign up now!
Alert icon
Upgrade to the latest Flash Player for improved playback performance. Upgrade now or more info.
245 views
Loading...
Alert icon
Sign in or sign up now!
Alert icon

Uploaded by on Feb 16, 2010

David J. Calkins, PhD, Director of Research and Associate Professor, Department of Ophthalmology
Vanderbilt Eye Institute discusses the Catalyst For a Cure (CFC): A New Model for Scientific Research.

The Calkins lab focuses on the mechanisms of neurodegeneration in glaucoma. Using systems, cellular and molecular approaches, they investigate how risk factors contribute to neurodegeneration and test new treatments. Dr. Calkins specializes in molecular mechanisms of the retina and optic nerve.

In this video: Benefits of Collaborative Research; The Focus of CFC Research; A Neurobiological Approach to Glaucoma Research.

Link to this comment:

Share to:
see all

All Comments (0)

Sign In or Sign Up now to post a comment!
Loading...

Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more